PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-09-07

Date Title Company
07-Sep-2022 Rockwell Medical Names Heather Hunter SVP, Chief Corporate Affairs Officer Businesswire
07-Sep-2022 Adaptive Phage Therapeutics Announces "The AMR RAPID™ Challenge" for the Infectious Disease Research Community: Find a Bacteria Resistant to APT’s Investigational Phage Bank Businesswire
07-Sep-2022 Baxter Expands Historically Black Colleges and Universities Partnerships, Funding Commitments to Further the Pipeline of Black Healthcare Professionals Businesswire
07-Sep-2022 Ernst and Young Selects Josh Eckman, CEO of Carterra, as 2022 Entrepreneur of the Year® Mountain West Award Winner Businesswire
07-Sep-2022 Sonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer Businesswire
07-Sep-2022 Aldeyra Therapeutics to Participate in Upcoming Investor Conferences Businesswire
07-Sep-2022 CONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder and Digihaler System to Help Improve Asthma Management Businesswire
07-Sep-2022 Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC Businesswire
07-Sep-2022 Azura Ophthalmics Secures Grant to Evaluate AZR-MD-001 for Improved Vision Quality Related to Contact Lens Discomfort Businesswire
07-Sep-2022 Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference Businesswire
07-Sep-2022 Seagen to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Businesswire
07-Sep-2022 Akanda to Participate in Benzinga Cannabis Capital Conference International Panel on September 13, 2022 Businesswire
07-Sep-2022 Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Businesswire
07-Sep-2022 Pyramid Biosciences Names Biren Amin as Chief Financial and Strategy Officer Businesswire
07-Sep-2022 Ian Read named Chairman of the Board of Areteia Therapeutics Businesswire
07-Sep-2022 GRO Biosciences Announces Addition of Nicole Paulk, PhD, to Scientific Advisory Board Businesswire
07-Sep-2022 Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles Businesswire
07-Sep-2022 ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine B3C newswire
07-Sep-2022 Otolith Labs Announces $20 Million Series A Financing by Morningside Ventures Businesswire
07-Sep-2022 Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference Businesswire